Sascha Weggen
Has participated in:
-
Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis
-
LRP1 is critical for the surface distribution and internalization of the NR2B NMDA receptor subtype
-
Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model
-
Untersuchungen zur Pathogenese SV40 large T-Antigen induzierter primitiver neuroektodermaler Tumoren (PNET) und zur Rolle von Polyomaviren bei der Entstehung humaner Gehirntumoren